These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11909838)

  • 1. In vitro action of carboxyfullerene.
    Tsao N; Luh TY; Chou CK; Chang TY; Wu JJ; Liu CC; Lei HY
    J Antimicrob Chemother; 2002 Apr; 49(4):641-9. PubMed ID: 11909838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of group A streptococcus infection by carboxyfullerene.
    Tsao N; Luh TY; Chou CK; Wu JJ; Lin YS; Lei HY
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1788-93. PubMed ID: 11353626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA.
    McCloskey L; Moore T; Niconovich N; Donald B; Broskey J; Jakielaszek C; Rittenhouse S; Coleman K
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():13-21. PubMed ID: 10824027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of cefdinir (FK482) and ten other antibiotics against gram-positive and gram-negative bacteria isolated from adult and pediatric patients.
    Sultan T; Baltch AL; Smith RP; Ritz W
    Chemotherapy; 1994; 40(2):80-91. PubMed ID: 8131638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents: special references to bacteria isolated between July 1996 and June 1997].
    Mashita K; Shinagawa N; Ishikawa S; Hirata K; Denno R; Mukaiya M; Mizuno A; Ishibiki K; Ushijima Y; Kinoshita H; Morimoto K; Aikawa N; Yamazaki M; Fujimoto M; Iwai S; Kato K; Tanimura H; Ohnishi H; Maeda T; Sato T; Tanaka N; Inoue F; Iwagaki H; Yura J; Tanaka S
    Jpn J Antibiot; 1999 May; 52(5):398-430. PubMed ID: 10480049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007-2009 study.
    Walkty A; Adam HJ; Laverdière M; Karlowsky JA; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):348-55. PubMed ID: 21353964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
    Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
    Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activity of Acalypha indica L.
    Govindarajan M; Jebanesan A; Reetha D; Amsath R; Pushpanathan T; Samidurai K
    Eur Rev Med Pharmacol Sci; 2008; 12(5):299-302. PubMed ID: 19024213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimicrobial spectrum of dalbavancin. Mechanism of action and in vitro activity against Gram-positive microorganisms].
    Cercenado E
    Enferm Infecc Microbiol Clin; 2017 Jan; 35 Suppl 1():9-14. PubMed ID: 28129822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial Properties of Tebipenem Pivoxil Tablet, a New Oral Carbapenem Preparation against a Variety of Pathogenic Bacteria in Vitro and in Vivo.
    Yao Q; Wang J; Cui T; Yang Z; Su M; Zhao P; Yan H; Zhan Y; Yang H
    Molecules; 2016 Jan; 21(1):62. PubMed ID: 26751436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gepotidacin (GSK2140944)
    Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme.
    Reynolds R; Potz N; Colman M; Williams A; Livermore D; MacGowan A;
    J Antimicrob Chemother; 2004 Jun; 53(6):1018-32. PubMed ID: 15128723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of pathogenic bacteria and drug resistance in neonatal purulent meningitis].
    Zhu M; Hu Q; Mai J; Lin Z
    Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):51-6. PubMed ID: 25748405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2010 and March 2011].
    Shinagawa N; Taniguchi M; Hirata K; Furuhata T; Fukuhara K; Mizugucwi T; Osanai H; Yanai Y; Hata F; Kihara C; Sasaki K; Oono K; Nakamura M; Shibuya H; Hasegawa I; Kimura M; Watabe K; Kobayashi Y; Yamaue H; Hirono S; Takesue Y; Fujiwara T; Shinoura S; Kimura H; Hoshikawa T; Oshima H; Aikawa N; Sasaki J; Suzuki M; Sekine K; Abe S; Takeyama H; Wakasugi T; Mashita K; Tanaka M; Mizuno A; Ishikawa M; Iwai A; Saito T; Muramoto M; Kubo S; Lee S; Fukuhara K; Iwagaki H; Tokunaga N; Sueda T; Hiyama E; Murakami Y; Ohge H; Uemura K; Tsumura H; Kanehiro T; Takeuchi H; Tanakaya K; Iwasaki M
    Jpn J Antibiot; 2014 Oct; 67(5):293-334. PubMed ID: 25549405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacteria isolated from surgical infections and their susceptibility to antimicrobial agents--special reference to bacteria isolated between April 2007 and March 2008].
    Shinagawa N; Hasegawa M; Hirata K; Katsuramaki T; Mizukuchi T; Ushijima Y; Ushida T; Aikawa N; Yo K; Yura J; Takeyama H; Wakasugi T; Taniguchi M; Mizuno I; Mashita K; Ishikawa S; Mizuno A; Tsumura H; Yokoyama T; Moori N; Sumita N; Kubo S; Lee S; Oomura T; Kobayashi Y; Tsuji T; Yamaue H; Kawai M; Takesue Y; Tanaka N; Kimura H; Iwagaki H; Sueda T; Hiyama E; Murakami Y; Ooge H; Uemura K; Takeuchi H; Yasui Y; Yasunami Y; Ryu S
    Jpn J Antibiot; 2009 Aug; 62(4):277-340. PubMed ID: 19860320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ceftazidime, ceftaroline and aztreonam alone and in combination with avibactam against European Gram-negative and Gram-positive clinical isolates.
    Testa R; Cantón R; Giani T; Morosini MI; Nichols WW; Seifert H; Stefanik D; Rossolini GM; Nordmann P
    Int J Antimicrob Agents; 2015 Jun; 45(6):641-6. PubMed ID: 25748553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of fosfomycin in vitro.
    Forsgren A; Walder M
    J Antimicrob Chemother; 1983 May; 11(5):467-71. PubMed ID: 6874631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.